Dr. Nicholas Burnham, DO

NPI: 1962795559
Total Payments
$195,344
2024 Payments
$27,684
Companies
2
Transactions
91
Medicare Patients
2,836
Medicare Billing
$225,174

Payment Breakdown by Category

Consulting$195,344 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $195,344 91 100.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $123,292 56 $0 (2024)
Shire North American Group Inc $72,052 35 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $27,684 12 Takeda Pharmaceuticals U.S.A., Inc. ($27,684)
2023 $18,056 8 Takeda Pharmaceuticals U.S.A., Inc. ($18,056)
2022 $26,484 12 Takeda Pharmaceuticals U.S.A., Inc. ($26,484)
2021 $25,784 12 Takeda Pharmaceuticals U.S.A., Inc. ($25,784)
2020 $25,284 12 Takeda Pharmaceuticals U.S.A., Inc. ($25,284)
2019 $24,584 12 Shire North American Group Inc ($24,584)
2018 $24,084 11 Shire North American Group Inc ($24,084)
2017 $23,384 12 Shire North American Group Inc ($23,384)

All Payment Transactions

91 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
12/15/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
11/10/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
10/09/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
09/13/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,307.00 General
07/14/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
06/14/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
04/07/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
02/08/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
12/07/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
11/09/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
10/05/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
09/09/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General
08/17/2022 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,207.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 733 774 $168,715 $54,347
2022 6 698 721 $160,558 $54,087
2021 5 702 716 $193,801 $58,667
2020 5 703 727 $194,514 $58,073
Total Patients
2,836
Total Services
2,938
Medicare Billing
$225,174
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 202 211 $85,455 $28,927 33.9%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 120 127 $35,306 $11,946 33.8%
99291 Critical care, first 30-74 minutes Facility 2023 48 48 $30,432 $8,009 26.3%
99283 Emergency department visit with low level of medical decision making Facility 2023 68 70 $11,480 $3,512 30.6%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 295 318 $6,042 $1,953 32.3%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 179 183 $71,187 $25,478 35.8%
99284 Emergency department visit for problem of high severity Facility 2022 132 134 $35,778 $12,577 35.2%
99291 Critical care, first 30-74 minutes Facility 2022 62 62 $37,758 $10,875 28.8%
99283 Emergency department visit for problem of moderate severity Facility 2022 60 61 $9,577 $3,098 32.3%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 250 265 $4,770 $1,650 34.6%
99282 Emergency department visit for problem of mild to moderate severity Facility 2022 15 16 $1,488 $408.98 27.5%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 173 177 $85,137 $25,968 30.5%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 78 79 $49,138 $14,361 29.2%
99284 Emergency department visit, problem of high severity Facility 2021 130 131 $43,230 $13,209 30.6%
99283 Emergency department visit, moderately severe problem Facility 2021 56 56 $9,744 $3,318 34.0%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2021 265 273 $6,552 $1,812 27.7%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 204 210 $97,039 $30,288 31.2%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 70 71 $42,484 $13,194 31.1%
99284 Emergency department visit, problem of high severity Facility 2020 107 109 $34,566 $9,825 28.4%
99283 Emergency department visit, moderately severe problem Facility 2020 58 59 $9,853 $2,853 29.0%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 264 278 $10,572 $1,913 18.1%

About Dr. Nicholas Burnham, DO

Dr. Nicholas Burnham, DO is a Emergency Medicine healthcare provider based in Great Falls, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1962795559.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Burnham, DO has received a total of $195,344 in payments from pharmaceutical and medical device companies, with $27,684 received in 2024. These payments were reported across 91 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($195,344).

As a Medicare-enrolled provider, Burnham has provided services to 2,836 Medicare beneficiaries, totaling 2,938 services with total Medicare billing of $225,174. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Great Falls, MT
  • Active Since 05/16/2011
  • Last Updated 04/05/2024
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1962795559

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Great Falls